What do you estimate that large and mid-tier pharmaceutical companies will spend on master data management (MDM) services and software from 2010 to 2012?
The money that pharma companies stand to save as a result of MDM will more than exceed their investments as long as they:
1. Deliberately plan their MDM programs. Successful MDM programs in pharma and health sciences mandate a requirements-driven, roadmap-enabled approach. This will also help with budgeting and resourcing -- ongoing challenges in many of these companies.
2. Apply rigor around their MDM investments. Pharma companies have a tendency to prefer vendors that are already in-house. We find that often translates into overinvestment.
Dig Deeper on MDM best practices
Related Q&A from Jill Dyché
Is it better for companies to go with an enterprise-wide master data management (MDM) implementation or deploy MDM departmentally? Find out which ... Continue Reading
There’s a lot of confusion about agile business intelligence (BI). Get an expert’s take on what agile BI really is and if it’s a valid BI development... Continue Reading
Are some companies primed to get more use out of social media analytics than others are? Find out, plus learn how a social media analytics strategy ... Continue Reading
Have a question for an expert?
Please add a title for your question
Get answers from a TechTarget expert on whatever's puzzling you.